Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: No effect on ablation outcome after ablation of atrial fibrillation

This publication has 32 references indexed in Scilit:

• Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
  American Heart Journal, 2006
• Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction
  Published by Elsevier ,2006
• Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence
  European Heart Journal, 2005
• Is atrial fibrillation an inflammatory disorder?
  European Heart Journal, 2005
• Inflammation in the genesis and perpetuation of atrial fibrillation
  European Heart Journal, 2005
• A Multicenter Risk Index for Atrial Fibrillation After Cardiac Surgery
  JAMA, 2004
• Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion
  The American Journal of Cardiology, 2003
• Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease
  The American Journal of Cardiology, 2003
• Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation Results of a prospective and controlled study
  Published by Oxford University Press (OUP) ,2003
• Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction
  Circulation, 2003